Shyra Gardai, chief scientific officer at the molecular glue start-up EpiBiologics, says Big Pharma’s recent interest in glue ...
On the heels of releasing its latest financial statement, Vancouver-based biotechnology company Absci announced it has met its first milestone in its collaboration with pharmaceutical giant AstraZenec ...
Analyst Silvan Tuerkcan of JMP Securities maintained a Buy rating on Terns Pharmaceuticals (TERN – Research Report), retaining the price ...
While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.
AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback